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We read with great interest the paper by Kadowaki and co-
workers on the expression of Reg protein in gastric cancer
cells, clearly depicted by immunohistochemistry in poorly dif-
ferentiated gastric carcinomas [1]. The authors speculate that
the Reg protein expression may lead to a growth advantage of
these cells. The alternative interpretation of the ¢nding is ob-
viously that the gastric carcinomas with Reg-positive tumour
cells originate from the ECL cell, which normally produces
Reg protein [2]. We have during more than a decade given
evidence for such an ECL cell origin of a proportion of gastric
carcinomas [3^7].
Neuroendocrine cells such as the ECL cell are characterised
by speci¢c secretory granules containing the general neuro-
endocrine marker chromogranin A (CgA). In neuroendocrine
tumours, there is a gradual loss of normal secretory granules
in the neoplastic cells during tumorigenesis and tumour pro-
gression. In such dedi¡erentiated and ‘degranulated’ neoplas-
tic cells the concentration of neuroendocrine cell markers is
low. Conventional methods used to visualise granules may
therefore show a negative reaction. However, CgA or CgA
mRNA may still be detected in many of these cells by using
more sensitive techniques.
We have studied ECL cell carcinoids and gastric adenocar-
cinomas using immunohistochemistry and the sensitive tyra-
mide signal ampli¢cation technique. With conventional immu-
nohistochemistry, most neoplastic cells in well-di¡erentiated
carcinoids stain with antibodies to CgA. In tumours with
poorly di¡erentiated ECL cells, however, only a few CgA-
positive cells can be detected. By increasing sensitivity with
tyramide signal ampli¢cation even poorly di¡erentiated ECL
cells show immunoreactivity toward CgA [5]. Viewed against
this background, we further examined gastric adenocarcino-
mas for CgA immunoreactivity [6,7]. With conventional im-
munohistochemistry only scattered CgA-positive cells could
be detected, but after signal ampli¢cation the number of
CgA-positive cells increased considerably in many tumours.
In poorly di¡erentiated carcinomas (Laure¤n di¡use type)
most of the neoplastic cells showed CgA immunoreactivity
(Fig. 1). Moreover, by using double staining for CgA and
Ki-67 [6] proliferating neuroendocrine cells could be found
in most tumours (Fig. 1). These tumours, previously classi¢ed
as adenocarcinomas, may therefore have a neuroendocrine/
ECL cell origin but have lost most of their neuroendocrine
characteristics during neoplastic transformation and progres-
sion. With sensitive techniques it is, however, possible to dis-
close their neuroendocrine origin.
The ¢ndings by Kadowaki and co-workers [1] support our
hypothesis that a proportion of gastric carcinomas originate
from the ECL cell and could thus explain Reg immunostain-
ing in such tumours. The growth stimulation of gastric carci-
noma cell lines by Reg protein could then be explained either
by an autocrine loop stimulation or by tumours with a non-
ECL cell origin possessing the Reg receptor [8].
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Fig. 1. Medium-power photomicrographs of a poorly di¡erentiated
gastric carcinoma (Laure¤n di¡use type) showing no CgA staining
(red/brown) with conventional immunohistochemistry (A). However,
with the more sensitive tyramide signal ampli¢cation technique,
most of the neoplastic cells show immunoreactivity (B, counterstain-
ing with Mayer’s haematoxylin). Two high-power insets with ‘dou-
ble’ staining are shown in the lower right corner illustrating prolifer-
ating neuroendocrine tumour cells with immunoreactivity for both
CgA (cytoplasmic staining) and Ki-67 (blue nuclear staining).
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